Acute hematogenous osteomyelitis
ICD-10 M86.0 is a billable code used to indicate a diagnosis of acute hematogenous osteomyelitis.
Acute hematogenous osteomyelitis is a severe bone infection that occurs when bacteria spread through the bloodstream to the bone, leading to inflammation and necrosis. This condition is most commonly seen in children but can occur in adults, particularly those with compromised immune systems or chronic conditions. The infection typically affects the long bones, such as the femur or tibia, and can result in severe pain, swelling, and fever. Diagnosis is often made through clinical evaluation, imaging studies such as MRI or CT scans, and laboratory tests that may reveal elevated inflammatory markers. Treatment usually involves a combination of antibiotics and, in some cases, surgical intervention to remove necrotic tissue. If left untreated, acute hematogenous osteomyelitis can lead to chronic osteomyelitis, which poses significant challenges in management and can result in long-term complications such as bone deformities or amputation.
Detailed clinical notes, imaging results, and treatment plans must be documented.
Patients presenting with bone pain, fever, and swelling after recent trauma or surgery.
Orthopedic surgeons should ensure that the surgical notes clearly indicate the presence of infection and any procedures performed to address it.
Comprehensive history of infection, laboratory results, and response to treatment.
Patients with systemic infections presenting with bone pain and elevated inflammatory markers.
Infectious disease specialists should document the source of infection and any underlying conditions that may predispose the patient to osteomyelitis.
Used when joint aspiration is performed to relieve pressure from an abscess.
Document the indication for the procedure and findings.
Orthopedic specialists should ensure that the procedure is clearly linked to the diagnosis of osteomyelitis.
Common causes include bacterial infections, particularly Staphylococcus aureus, and conditions that compromise the immune system, such as diabetes or IV drug use.
Diagnosis typically involves clinical evaluation, imaging studies like MRI or CT scans, and laboratory tests that may show elevated inflammatory markers.
